0001085037-20-000009.txt : 20200211
0001085037-20-000009.hdr.sgml : 20200211
20200211133211
ACCESSION NUMBER: 0001085037-20-000009
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200211
DATE AS OF CHANGE: 20200211
EFFECTIVENESS DATE: 20200211
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: WPD Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001798073
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0131
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-360240
FILM NUMBER: 20595638
BUSINESS ADDRESS:
STREET 1: SUITE 1080, 789 WEST PENDER STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1H2
BUSINESS PHONE: 604 428-7050
MAIL ADDRESS:
STREET 1: SUITE 1080, 789 WEST PENDER STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1H2
FORMER COMPANY:
FORMER CONFORMED NAME: Westcot Ventures Corp.
DATE OF NAME CHANGE: 20191226
D
1
primary_doc.xml
X0708
D
LIVE
0001798073
WPD Pharmaceuticals Inc.
SUITE 1080, 789 WEST PENDER STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 1H2
604 428-7050
BRITISH COLUMBIA, CANADA
Westcot Ventures Corp.
Corporation
true
Liam
Lake
Corcoran
1288 West Cordova Street
Suite 2807
Vancouver
A1
BRITISH COLUMBIA, CANADA
V6C 3R3
Executive Officer
Director
Canadian Vice President and Corporate Secretary
Christopher
Cherry
2141 Grand Blvd.
North Vancouver
A1
BRITISH COLUMBIA, CANADA
V7L 3Y8
Executive Officer
Chief Financial Officer
Teresa
Rzepczyk
325 Tucker Crt
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1V 2S9
Director
Walter
Klemp
1973 W Clay Street
Houston
TX
TEXAS
77019
Director
Peter
Novak
739 Longmeadow Street
Longmeadow
MA
MASSACHUSETTS
01106
Director
Mariusz
Olejniczak
Zwirki i Wigury 101
Warszawa
R9
POLAND
02-089
Executive Officer
Chief Executive Officer
Other
Decline to Disclose
- 06b
false
true
true
true
true
false
0
889790
0
889790
CDN$1,161,000 based on Bank of Canada Exchange rate of $0.7664 on January 13, 2020. Represents stock options to purchase 1,350,000 common shares at an exercise price of CDN$0.86 per share.
false
3
0
0
0
false
WPD Pharmaceuticals Inc.
/s/ Mariusz Olejniczak
Mariusz Olejniczak
Chief Executive Officer
2020-02-11